secwatch.observer — SEC 8-K summary
======================================

Issuer:     VBI Vaccines Inc/BC (—)
CIK:        0000764195
Form:       8-K
Filed at:   2025-01-03T23:59:59+00:00
Accession:  0001493152-25-000271
Event type: other_material
Sentiment:  negative
Materiality: 1.00
Item codes: 2.01, 3.03, 5.01, 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

VBI Vaccines completes sale to K2 HealthVentures affiliate; common shares cancelled for no value, company to deregister
--------------------------------------------------------------------------------

- All outstanding common shares redeemed and cancelled without consideration; existing shareholders receive zero.
- Company and subsidiaries become wholly owned by K2 VBI Equity Trust (K2 HealthVentures affiliate) and exit CCAA protection.
- All directors and executive officers resigned; replaced by nominees of K2.
- Company plans to cease reporting issuer status in Canada and deregister shares under SEC.
- Transaction closed January 3, 2025, per court-approved acquisition agreement dated Oct 24, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/764195/000149315225000271/0001493152-25-000271-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/764195/000149315225000271/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-000271

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer